Hashimoto A, Tanaka Y, Ishikawa T, Shinzato I. Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
Clin Case Rep 2021;
9:e04417. [PMID:
34322242 PMCID:
PMC8301558 DOI:
10.1002/ccr3.4417]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Revised: 05/21/2020] [Accepted: 06/15/2020] [Indexed: 12/04/2022] Open
Abstract
A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.
Collapse